|
WO2013007704A2
|
|
Novel sdf-1-based glycosaminoglycan antagonist and methods of using same
|
|
EP2686344A1
|
|
Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same
|
|
CA2773664A1
|
|
Composition for treatment of cxcl8-mediated lung inflammation
|
|
WO2010122176A1
|
|
A method to identify glycosaminoglycan (gag) binding sites in proteins
|
|
CA2750983A1
|
|
Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
|
|
EP2053060A1
|
|
SDF-1-based glyocosaminoglycan antagonists and methods of using same
|
|
EP2042516A1
|
|
Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same
|
|
AT504685A1
|
|
Fusion protein
|
|
AT504367B1
|
|
Method for measuring the biological activity of chemoattraktants
|
|
EP1894571A1
|
|
Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection
|
|
EP2363411A1
|
|
GAG binding proteins
|
